Double infection in a patient with psoriatic arthritis under TNF-alpha blockers therapy: a case report.

CONCLUSION: This case highlights the importance to consider the possibility to develop leishmaniasis and/or non-tubercular mycobacterial infection in patients treated with TNF-apha inhibitors. PMID: 30648521 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30648521?dopt=Abstract

Source: Current Drug Safety - January 14, 2019 Category: Drugs & Pharmacology Authors: Caroleo B, Migliore A, Cione E, Zampogna S, Perticone F, Sarro G, Gallelli L Tags: Curr Drug Saf Source Type: research